Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR1 | P30556 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7313661 | 0.95 | AGTR1 (0.55) | AGTR1 | |
| SCHEMBL7310124 | 0.94 | AGTR1 (0.52) | AGTR1 | |
| SCHEMBL7306139 | 0.93 | AGTR1 (0.52) | AGTR1 | |
| SCHEMBL7306519 | 0.93 | — | — | |
| SCHEMBL7300922 | 0.90 | AGTR1 (0.55) | AGTR1 | |
| SCHEMBL7308914 | 0.89 | — | — | |
| SCHEMBL7310146 | 0.88 | AGTR1 (0.55) | AGTR1 | |
| SCHEMBL7302096 | 0.88 | AGTR1 (0.48) | AGTR1 | |
| SCHEMBL7303432 | 0.87 | — | — | |
| SCHEMBL7303467 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5310927-A | Hypotensive agents; cognition activators; imidazolyl-2-aryl derivatives | GLAXO GROUP LIMITED (GB) | 1994-05-10 | — | — | US | claimed |
| EP-0514193-A1 | N-linked imidazolyl-methyl benzofuran derivatives with antihypotensive activity | GLAXO GROUP LIMITED (GB) | 1992-11-19 | — | — | EP | claimed |
| US-5310927-A | Hypotensive agents; cognition activators; imidazolyl-2-aryl derivatives | GLAXO GROUP LIMITED (GB) | 1994-05-10 | — | — | US | disclosed |
| EP-0514193-A1 | N-linked imidazolyl-methyl benzofuran derivatives with antihypotensive activity | GLAXO GROUP LIMITED (GB) | 1992-11-19 | — | — | EP | disclosed |